GnRH agonist long protocol vs. a single 3-mg GnRH antagonist: A comparison of 2 protocols for pituitary down-regulation in oocyte donor-controlled ovarian hyperstimulation cycles

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 53, Issue 5, 2008, Pages 331-337

  Erb, Teresa M ^a,b   Wakim, Anthony N G ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Assisted reproductive techniques; GnRH agonists; GnRH antagonists; Gonadotropins; Oocyte donation

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; RECOMBINANT FOLLITROPIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE TEST; CLINICAL PROTOCOL; DOWN REGULATION; DRUG DOSE REDUCTION; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE FERTILITY; FERTILIZATION IN VITRO; HEALTH PROGRAM; HUMAN; HUMAN CELL; HUMAN EMBRYO; HYPOPHYSIS; MEDICAL SCHOOL; NIDATION; NORMAL HUMAN; OOCYTE DONATION; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RANK SUM TEST; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE;

ADULT; CLINICAL PROTOCOLS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OOCYTE DONATION; OVULATION INDUCTION; RETROSPECTIVE STUDIES;

EID: 45349095447     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Albano C, Smitz J, Tournaye H, et al: Luteal phase and clinical outcome after human menopausal gonadotropin/gonadotropin releasing hormone antagonist treatment of ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles. Hum Reprod 1999;14:1426-1430
2. Liu HC, Lai YM, Davis O: Improved pregnancy outcomes with gonadotropin releasing hormone agonist stimulation is due to improved oocyte quantity rather than quality. J Assist Reprod Genet 1992;9:338-342
3. Felberbaum RE, Diedrich K: Ovarian stimulation for IVF/ICSI with gonadotrophins and GnRH analogues: Agonists and antagonists. Hum Reprod 1999;14:207-221
4. Ben-Rafael Z, Lipitz S, Bider D, et al: Ovarian hyporesponsiveness in combined GnRH-agonist and menotropin therapy is associated with decreased serum FSH levels. Fertil Steril 1991;55:272-275
5. Whelan NG, Stella J: The ovarian hyperstimulation syndrome. Fertil Steril 2000;73:883-896
6. Lindheim SR, Morales AJ: GnRH antagonist followed by a decrease in serum estradiol results in adverse outcomes in donor oocyte cycles. Hum Reprod 2003;18:2023-2031
7. Riccarelli E, Sanchez M, Martinez M, et al: Impact of GnRH antagonists in oocyte donation cycles. Fertil Steril 2003;75:18-22
8. Olivennes F, Alvarez S, Bouchard P, et al: The use of a GnRH antagonist (cetrorelix) in a single dose protocol in IVF/ET: A dose finding study of 3 versus 2 mg. Hum Reprod 1998;13:2411-2414
9. Albano C, Felberbaum RE, Smith J, et al: Ovarian stimulation with HMG: Results of a prospective randomized phase III European study comparing the lutenizing releasing hormone antagonist cetrorelix and the LHRH-agonist buserelin: European Cetrorelix Study Group. Hum Reprod 2000;15:526-531
10. Hohmann FP, Macklon NS, Flauser BC: A randomized comparison of two ovarian stimulation protocols with GnRH antagonist cotreatment for IVF commencing rFSH on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab 2003;88:166-173
11. Ludwig M, Katalinic A, Diedrich K: Use of GnRH antagonists in ovarian stimulation for ART compared with the long protocol: A meta-analysis. Arch Gynecol Obstet 2001;265:175-182
12. Al-Inany H, Aboulghar M: GnRH antagonist in assisted reproduction: A Cochrane review. Hum Reprod 2002;17:874-887
13. Westergaard LG, Laursen SB, Andersen CY: Increased risk of early pregnancy loss by profound suppression of LH during ovarian stimulation in normogonadotropic women undergoing assisted reproduction. Hum Reprod 2000;15:1003-1008
14. Prapas N, Prapas Y, Panagiotidis Y, et al: GnRH agonist versus GnRH antagonist in oocyte donation cycles: A prospective randomized study. Hum Reprod 2005;20:1516-1520
15. Kolibianakis EM, Albano C, Kahn J, et al: Exposure to high levels of LH and estradiol in early follicular phase of GnRH antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril 2003;79:873-880
16. Tarlatzis BC, Fauser BC, Kolibianiakis EM, et al: GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 2006;12:333-340